NeOnc Technologies Holdings, Inc. (NTHI)
NASDAQ: NTHI · Real-Time Price · USD
5.53
+0.62 (12.63%)
At close: Aug 18, 2026, 4:00 PM EDT
5.48
-0.05 (-0.90%)
After-hours: Aug 18, 2026, 7:13 PM EDT
NTHI Revenue
NeOnc Technologies Holdings had revenue of $39.99K in the twelve months ending June 30, 2026, up 99.95% year-over-year. In the year 2025, NeOnc Technologies Holdings had annual revenue of $39.99K, down -51.82%.
Revenue (ttm)
$39.99K
Revenue Growth
+99.95%
P/S Ratio
3,437.31
Revenue / Employee
$7,998
Employees
5
Market Cap
137.46M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 39.99K | -43.01K | -51.82% |
| Dec 31, 2024 | 83.00K | 12.54K | 17.79% |
| Dec 31, 2023 | 70.46K | 50.46K | 252.31% |
| Dec 31, 2022 | 20.00K | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| LENZ Therapeutics | 21.48M |
| Equillium | 4.39M |
| NRx Pharmaceuticals | 3.39M |
| Milestone Pharmaceuticals | 2.34M |
| Outlook Therapeutics | -1.16M |
NTHI News
- 9 hours ago - NeOnc Technologies- Talk Is Cheap, Insider Buying Isn't - GlobeNewsWire
- 1 day ago - These Nasdaq Stories Are Heating Up - GlobeNewsWire
- 1 day ago - NTHI's Nasdaq Advantage Takes on New Meaning After Its Breakthrough Phase 2a Results - GlobeNewsWire
- 1 day ago - NeOnc says Phase 2a portion of NEO100-01 study met primary endpoint - TheFly
- 4 days ago - NeOnc Technologies Holdings Transcript: AGM 2026 - Transcripts
- 5 days ago - Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) 2Q26 - Newsfile Corp
- 5 days ago - The Nose Knows: Why NeOnc's Patent Portfolio Could Make NTHI More Than a One-Drug Biotech - GlobeNewsWire
- 6 days ago - Targeting The Mutant: NTHI's NEO100 Data Could Open a New Front in the Fight Against Brain Cancer - GlobeNewsWire